161 related articles for article (PubMed ID: 25093464)
1. Determinants of Long-Term Persistence with Tiotropium Bromide for Chronic Obstructive Pulmonary Disease.
Tanaka K; Kamiishi N; Miyata J; Kabata H; Masaki K; Ogura-Tomomatsu H; Tomomatsu K; Suzuki Y; Fukunaga K; Sayama K; Betsuyaku T; Asano K
COPD; 2015 Jun; 12(3):233-9. PubMed ID: 25093464
[TBL] [Abstract][Full Text] [Related]
2. Cost-effectiveness and budget impact of the fixed-dose dual bronchodilator combination tiotropium-olodaterol for patients with COPD in the Netherlands.
van Boven JF; Kocks JW; Postma MJ
Int J Chron Obstruct Pulmon Dis; 2016; 11():2191-2201. PubMed ID: 27703341
[TBL] [Abstract][Full Text] [Related]
3. Early impact of treatment with tiotropium, long-acting anticholinergic preparation, in patients with COPD - real-life experience from an observational study.
Jahnz-Różyk K; Szepiel P
Int J Chron Obstruct Pulmon Dis; 2015; 10():613-23. PubMed ID: 25834420
[TBL] [Abstract][Full Text] [Related]
4. A 4-year trial of tiotropium in chronic obstructive pulmonary disease.
Tashkin DP; Celli B; Senn S; Burkhart D; Kesten S; Menjoge S; Decramer M;
N Engl J Med; 2008 Oct; 359(15):1543-54. PubMed ID: 18836213
[TBL] [Abstract][Full Text] [Related]
5. Effect of tiotropium on outcomes in patients with moderate chronic obstructive pulmonary disease (UPLIFT): a prespecified subgroup analysis of a randomised controlled trial.
Decramer M; Celli B; Kesten S; Lystig T; Mehra S; Tashkin DP;
Lancet; 2009 Oct; 374(9696):1171-8. PubMed ID: 19716598
[TBL] [Abstract][Full Text] [Related]
6. Tiotropium bromide, a new long-acting antimuscarinic bronchodilator: a pharmacodynamic study in patients with chronic obstructive pulmonary disease (COPD). Dutch Study Group.
Maesen FP; Smeets JJ; Sledsens TJ; Wald FD; Cornelissen PJ
Eur Respir J; 1995 Sep; 8(9):1506-13. PubMed ID: 8575576
[TBL] [Abstract][Full Text] [Related]
7. A randomized multicenter Phase II study of perioperative tiotropium intervention in gastric cancer patients with chronic obstructive pulmonary disease.
Fushida S; Oyama K; Kaji M; Hirono Y; Kinoshita J; Tsukada T; Nezuka H; Nakano T; Noto M; Nishijima K; Fujimura T; Ohta T
Int J Chron Obstruct Pulmon Dis; 2015; 10():2177-83. PubMed ID: 26491284
[TBL] [Abstract][Full Text] [Related]
8. Describing drivers of and barriers to persistence with tiotropium in patients with chronic obstructive pulmonary disease: a mixed-methods approach.
Bereznicki BJ; Peterson GM; Jackson SL; Walters H; Hardley FL; Gavagna GA; Marshall DC
Int J Pharm Pract; 2015 Apr; 23(2):154-7. PubMed ID: 24934828
[TBL] [Abstract][Full Text] [Related]
9. Cost-Effectiveness of Glycopyrronium Bromide Compared with Tiotropium in Patients with Chronic Obstructive Pulmonary Disease in Sweden.
Costa-Scharplatz M; Ställberg B; Goyal P; Asukai Y; Gruenberger JB; Price D
Appl Health Econ Health Policy; 2015 Dec; 13(6):637-45. PubMed ID: 26324401
[TBL] [Abstract][Full Text] [Related]
10. Impact of tiotropium on the course of moderate-to-very severe chronic obstructive pulmonary disease: the UPLIFT trial.
Tashkin DP
Expert Rev Respir Med; 2010 Jun; 4(3):279-89. PubMed ID: 20524910
[TBL] [Abstract][Full Text] [Related]
11. Effect of tiotropium on lung function decline in early-stage of chronic obstructive pulmonary disease patients: propensity score-matched analysis of real-world data.
Lee HY; Choi SM; Lee J; Park YS; Lee CH; Kim DK; Lee SM; Yoon HI; Yim JJ; Kim YW; Han SK; Yoo CG
Int J Chron Obstruct Pulmon Dis; 2015; 10():2185-92. PubMed ID: 26508848
[TBL] [Abstract][Full Text] [Related]
12. [Efficacy of tiotropium bromide (Spiriva) in patients with chronic-obstructive pulmonary disease (COPD) of different severities].
Beeh KM; Beier J; Buhl R; Stark-Lorenzen P; Gerken F; Metzdorf N;
Pneumologie; 2006 Jun; 60(6):341-6. PubMed ID: 16761228
[TBL] [Abstract][Full Text] [Related]
13. Predictors of short-term LAMA ineffectiveness in treatment naïve patients with moderate to severe COPD.
Fijačko V; Labor M; Fijačko M; Škrinjarić-Cincar S; Labor S; Dumbović Dubravčić I; Bačun T; Včev A; Popović-Grle S; Plavec D
Wien Klin Wochenschr; 2018 Apr; 130(7-8):247-258. PubMed ID: 29322375
[TBL] [Abstract][Full Text] [Related]
14. Tiotropium bromide: a new long-acting bronchodilator for the treatment of chronic obstructive pulmonary disease.
Koumis T; Samuel S
Clin Ther; 2005 Apr; 27(4):377-92. PubMed ID: 15922812
[TBL] [Abstract][Full Text] [Related]
15. Does quality of life of COPD patients as measured by the generic EuroQol five-dimension questionnaire differentiate between COPD severity stages?
Rutten-van Mölken MP; Oostenbrink JB; Tashkin DP; Burkhart D; Monz BU
Chest; 2006 Oct; 130(4):1117-28. PubMed ID: 17035446
[TBL] [Abstract][Full Text] [Related]
16. Short-term effects of inhalative tiotropium/formoterol/budenoside versus tiotropium/formoterol in patients with newly diagnosed chronic obstructive pulmonary disease requiring surgery for lung cancer: a prospective randomized trial.
Bölükbas S; Eberlein M; Eckhoff J; Schirren J
Eur J Cardiothorac Surg; 2011 Jun; 39(6):995-1000. PubMed ID: 20970351
[TBL] [Abstract][Full Text] [Related]
17. Indacaterol and tiotropium combination therapy in patients with chronic obstructive pulmonary disease.
Matsushima S; Inui N; Yasui H; Kono M; Nakamura Y; Toyoshima M; Shirai T; Suda T
Pulm Pharmacol Ther; 2015 Feb; 30():11-5. PubMed ID: 25445929
[TBL] [Abstract][Full Text] [Related]
18. Factors associated with early adherence to tiotropium in chronic obstructive pulmonary disease.
Laforest L; Licaj I; Devouassoux G; Hartwig S; Marvalin S; Van Ganse E
Chron Respir Dis; 2013 Feb; 10(1):11-8. PubMed ID: 23149384
[TBL] [Abstract][Full Text] [Related]
19. The 24-h lung-function profile of once-daily tiotropium and olodaterol fixed-dose combination in chronic obstructive pulmonary disease.
Beeh KM; Westerman J; Kirsten AM; Hébert J; Grönke L; Hamilton A; Tetzlaff K; Derom E
Pulm Pharmacol Ther; 2015 Jun; 32():53-9. PubMed ID: 25956072
[TBL] [Abstract][Full Text] [Related]
20. COPD in young patients: a pre-specified analysis of the four-year trial of tiotropium (UPLIFT).
Morice AH; Celli B; Kesten S; Lystig T; Tashkin D; Decramer M
Respir Med; 2010 Nov; 104(11):1659-67. PubMed ID: 20724131
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
